文献速递系统性红斑狼疮其他结缔组织病

宫内暴露于Ro/SSA和La/SSB自身抗体的新生儿I型干扰素系统激活

Type I IFN system activation in newborns exposed to Ro/SSA and La/SSB autoantibodies in utero.
PubMed 文献 · RMD Open · 2020-01-01

本研究检测抗Ro/La阳性母亲及其新生儿血浆和PBMC,发现母儿均存在干扰素调节基因表达升高和血浆IFNα水平升高,新生儿CD14+单核细胞活化;母亲接受免疫调节治疗的新生儿IFN评分与对照相似,且抗Ro/La阳性血浆可诱导母儿PBMC产生IFNα。

要点

  • 抗Ro/La阳性母亲及其新生儿均显示I型干扰素系统激活。
  • 母亲免疫调节治疗可能降低新生儿干扰素调节基因表达。
  • 抗Ro/La阳性血浆可在体外诱导母儿PBMC产生IFNα。

核心结论

  • 宫内暴露于Ro/La自身抗体的新生儿存在免疫系统激活和IFN特征。
  • 新生儿细胞在暴露于含自身抗体血浆时可产生IFNα。
  • 母亲免疫调节治疗可能减弱胎儿IFN调节基因的表达。

研究设计与样本

  • 研究纳入抗Ro/La阳性母亲、其新生儿及健康对照配对,采集出生时血液分离血浆和PBMC。
  • PBMC直接分析或培养,采用微阵列分析mRNA表达、流式细胞术检测细胞表面标志、免疫分析检测IFNα水平。

主要发现

  • 抗Ro/La阳性母亲及其新生儿均显示IFN调节基因表达增加和血浆IFNα水平升高。
  • 抗Ro/La阳性母亲及其新生儿CD14+单核细胞中Sialic acid-binding Ig-like lectin-1表达增加,提示细胞活化。
  • 接受免疫调节治疗的母亲所生新生儿IFN评分与对照相似,尽管母亲持续存在IFN激活。
  • 母儿PBMC与抗Ro/La阳性血浆共培养时可诱导IFNα产生。

临床怎么用

  • 对于抗Ro/La阳性母亲的新生儿,需关注I型干扰素系统激活状态。
  • 母亲免疫调节治疗可能影响新生儿IFN特征,需进一步研究其临床意义。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: In utero exposure of the fetus to Ro/La autoantibodies may lead to congenital heart block (CHB). In the mother, these autoantibodies are associated with activation of the type I interferon (IFN)-system. As maternal autoantibodies are transferred to the fetus during pregnancy, we investigated whether the type I IFN-system is activated also in newborns of anti-Ro/La positive mothers, and whether fetal IFN activation is affected by maternal immunomodulatory treatment. METHODS: Blood drawn at birth from anti-Ro/La positive mothers, their newborns and healthy control pairs was separated into plasma and peripheral blood mononuclear cells (PBMC). PBMC were analysed directly or cultured. mRNA expression was analysed by microarrays, cell surface markers by flow cytometry, and IFNα levels by immunoassays. RESULTS: We observed increased expression of IFN-regulated genes and elevated plasma IFNα levels not only in anti-Ro/La positive women, but also in their newborns. CD14+ monocytes of both anti-Ro/La positive mothers and their neonates showed increased expression of Sialic acid-binding Ig-like lectin-1, indicating cellular activation. Notably, the IFN score of neonates born to mothers receiving immunomodulatory treatment was similar to that of controls, despite persistent IFN activation in the mothers. In both maternal and neonatal PBMC, IFNα production was induced when cells were cultured with anti-Ro/La positive plasma. CONCLUSIONS: Ro/La autoantibody-exposed neonates at risk of CHB have signs of an activated immune system with an IFN signature. This study further demonstrates that neonatal cells can produce IFNα when exposed to autoantibody-containing plasma, and that maternal immunomodulatory treatment may diminish the expression of IFN-regulated genes in the fetus.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Hedlund M, Thorlacius GE, Ivanchenko M, et al. Type I IFN system activation in newborns exposed to Ro/SSA and La/SSB autoantibodies in utero. RMD Open. 2020. PMID: 31958275. doi:10.1136/rmdopen-2019-000989

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。